Hemming L. Johansson
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91 publications
A decade later - assessing hearing preservation in vestibular schwannoma patients post middle cranial fossa surgery.
Journal: Acta oto-laryngologica
Published: February 04, 2026
Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial.
Journal: Nature communications
Published: August 29, 2025
Prospective Assessment of Clinically Relevant Fluid Balance Thresholds Associated With Postoperative Complications in Advanced Ovarian Cancer.
Journal: Acta anaesthesiologica Scandinavica
Published: March 11, 2025
Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trial.
Journal: The Lancet regional health. Europe
Published: September 02, 2024
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 17, 2024
Effect of intraperitoneal ropivacaine during and after cytoreductive surgery on time-interval to adjuvant chemotherapy in advanced ovarian cancer: a randomised, double-blind phase III trial.
Journal: British journal of anaesthesia
Published: July 04, 2024
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial.
Journal: NPJ breast cancer
Published: June 23, 2024
Comparison between Swedish EORTC QLQ-C30 general population norm data published in 2000 and 2019.
Journal: Acta oncologica (Stockholm, Sweden)
Published: October 20, 2023
Prognostic value of bone marrow and tumor 18F-FDG uptake on PET/CT in patients with oropharyngeal cancer and the interplay between inflammation and FDG uptake.
Journal: Head & neck
Published: October 08, 2023
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial.
Journal: Breast cancer research and treatment
Published: July 24, 2023
Incidence of cardiovascular and bleeding events and reasons for discontinuation in patients with chronic lymphocytic leukemia treated with ibrutinib-A retrospective analysis on consecutive patients from a well-defined region.
Journal: European journal of haematology
Published: June 05, 2023
Idelalisib (PI3Kδ inhibitor) therapy for patients with relapsed/refractory chronic lymphocytic leukemia: A Swedish nation-wide real-world report on consecutively identified patients.
Journal: European journal of haematology
Published: May 15, 2023
Last Updated: 09/26/2026